CD274 and adenocarcinoma: Amongst the squamous cell carcinomas, 58.7% were positive for PD-L1, while 50.0% of all the adenocarcinomas and 72.7% of all the adenosquamous carcinomas were positive with PD-L1 immunohistochemical stain.